SILVERCREST ASSET MANAGEMENT GROUP LLC - F-STAR THERAPEUTICS INC ownership

F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 27 filers reported holding F-STAR THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SILVERCREST ASSET MANAGEMENT GROUP LLC ownership history of F-STAR THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$79,537
+24.3%
12,5850.0%0.00%0.0%
Q3 2022$64,000
-19.0%
12,5850.0%0.00%0.0%
Q2 2022$79,000
+75.6%
12,5850.0%0.00%
Q1 2022$45,000
-28.6%
12,5850.0%0.00%
Q4 2021$63,000
-33.0%
12,585
-1.9%
0.00%
-100.0%
Q3 2021$94,000
-14.5%
12,8350.0%0.00%0.0%
Q2 2021$110,000
-20.9%
12,8350.0%0.00%0.0%
Q1 2021$139,000
+9.4%
12,8350.0%0.00%0.0%
Q4 2020$127,00012,8350.00%
Other shareholders
F-STAR THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 714,285$6,136,0001.28%
Boxer Capital, LLC 1,751,428$15,045,0000.53%
Atlas Venture Advisors, Inc. 574,996$4,939,0000.51%
Monashee Investment Management LLC 400,000$3,436,0000.41%
Connolly Sarah T. 53,001$455,0000.37%
Rock Springs Capital Management LP 1,054,232$9,056,0000.18%
Eversept Partners, LP 100,000$859,0000.06%
Maven Securities LTD 144,932$1,257,0000.05%
Point72 Asset Management, L.P. 1,075,000$9,234,0000.04%
Private Capital Advisors, Inc. 13,083$112,0000.02%
View complete list of F-STAR THERAPEUTICS INC shareholders